CompletedNot Applicable

Effectiveness of a Cognitive Training Program (UMAM Method) in Elderly People Without Dementia

Spain199 participantsStarted 2013-10

Plain-language summary

The study is oriented to analyze the effectiveness of a cognitive training method (UMAM) on cognitive functions, subjective memory and mood state in elderly people without dementia. On the other hand, the study aims to examine whether variables such as cognitive reserve (e.g. educational level), APOE genotype and intracranial volume are related to increased benefit after the intervention. The researchers hope to find that greater cognitive reserve, not having the APOE allele ε4, and a greater volume of memory-related brain areas, are associated with better outcomes after the cognitive intervention.

Who can participate

Age range

60 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Being over 60 years old. * Having a global cognitive performance \> 23 in the Mini Mental State Examination Test. * Having no history of neurological or serious psychiatric disorders (severe psycho-affective disorders and psychosis or other psychiatric disorders like alcoholism). Exclusion Criteria: * Chronic use of anxiolytics. * Chronic use of neuroleptics. * Chronic use of anticonvulsants. * Having hearing or vision impairments that would preclude testing. * Magnetic Resonance Imaging (MRI) contraindications.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Change in general cognition

Timeframe: This cognitive variable was assessed before and after the intervention. The interval between the pre and post-intervention assessment was 6 months.

Change in verbal memory

Timeframe: This cognitive variable was assessed before and after the intervention. The interval between the pre and post-intervention assessment was 6 months.

Change in logical memory

Timeframe: This cognitive variable was assessed before and after the intervention. The interval between the pre and post-intervention assessment was 6 months.

Change in visual memory

Timeframe: This cognitive variable was assessed before and after the intervention. The interval between the pre and post-intervention assessment was 6 months.

Change in daily memory

Timeframe: This cognitive variable was assessed before and after the intervention. The interval between the pre and post-intervention assessment was 6 months.

Change in attentional amplitude

Timeframe: This cognitive variable was assessed before and after the intervention. The interval between the pre and post-intervention assessment was 6 months.

Trial details

NCT IDNCT04245579

SponsorMadrid Salud

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2015-05

View on ClinicalTrials.gov More Age-Related Memory Disorders trials

Plain-language summary

Who can participate

Age range

60 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

Change in general cognition

Timeframe: This cognitive variable was assessed before and after the intervention. The interval between the pre and post-intervention assessment was 6 months.

Change in verbal memory

Timeframe: This cognitive variable was assessed before and after the intervention. The interval between the pre and post-intervention assessment was 6 months.

Change in logical memory

Timeframe: This cognitive variable was assessed before and after the intervention. The interval between the pre and post-intervention assessment was 6 months.

Change in visual memory

Timeframe: This cognitive variable was assessed before and after the intervention. The interval between the pre and post-intervention assessment was 6 months.

Change in daily memory

Timeframe: This cognitive variable was assessed before and after the intervention. The interval between the pre and post-intervention assessment was 6 months.

Change in attentional amplitude

Timeframe: This cognitive variable was assessed before and after the intervention. The interval between the pre and post-intervention assessment was 6 months.